Radiation Therapy Improves Survival Outcome in Pancreatic Adenocarcinoma: Comparison of a 15-Year Institutional Experience at the University of Nebraska Medical Center with SEER Data
Table 1
Demographics.
UNMC
SEER
()c
561
60587
Age (%)
≤68
278 (49.55%)
28924 (47.74%)
0.8
>68
383 (50.45%)
31663 (52.26%)
Gender (%)
Male
321 (57.22%)
29599 (48.85%)
0.2
Female
240 (42.78%)
30988 (51.15%)
Race (%)
White
516 (91.98%)
49089 (81.02%)
0.02
Nonwhite
45 (8.02%)
11498 (18.98%)
Stage (%)
I
48 (8.56%)
II
150 (26.74%)
III
79 (14.08%)
IV
284 (50.62%)
Local
4384 (7.24%)
Regional
18782 (31.00%)
Distant
37421 (61.76%)
Surgery (%)
No
446 (79.50%)
51598 (85.16%)
0.29
Yes
115 (20.50%)
8989 (14.84%)
Radiation (%)
No
383 (68.27%)
48975 (80.83%)
0.04
Yes
178 (31.73%)
11612 (19.17%)
Chemotherapy (%)
No
151 (26.92%)
Yes
410 (73.08%)
Year of diagnosis (%)
1995–1999
129 (22.99%)
9628 (15.89%)
0.03
2000–2003
94 (16.76%)
17950 (29.63%)
2004–2006
86 (15.33%)
15513 (25.60%)
2007–2011/2009a
252 (44.92%)
17496 (28.88%)
Living (%)
Yes
51 (9.09%)
5533 (9.13%)
0.8
No
510 (90.91%)
55054 (90.87%)
UNMC Data extended to 2011 to enhance patient numbers.
bNonstage IV was grouped together and was compared to stage IV.
cPercentage of each category was compared.
